The drugmaker will pay AI therapeutics company Insitro $40 million upfront and up to $1.46 billion subject to meeting targets ...

By Patrick Wingrove LONDON, Oct 15 (Reuters) - AstraZeneca has teamed up with artificial intelligence biotech company insitro ...

TDB will provide Rs 86 crore to Peptris Technologies for a Rs 172-crore project to advance four AI-discovered experimental ...

Can AI drug discovery stocks become the next NVIDIA?A thorough comparison of the future potential and financial risks of RXRX ...

Partnerships, licensing, capacity expansion, AI integration, thermostable formulations and decentralized manufacturing are key strategies for faster development and new revenue streams.Dublin, Oct. 15 ...

Detailed analyses of ligand choice, linkage vector and linker length enabled the development of bitopic inhibitors of ABL1 and EGFR kinases, including an ABL1 inhibitor with enhanced activity against ...

There has been another major milestone in the field of AI-driven drug discovery (AI drug discovery).I would like to organize ...

Indian scientists and biopharmaceutical firms are using artificial intelligence to identify promising drug candidates faster ...

AstraZeneca has entered into a strategic drug discovery collaboration and licensing agreement with insitro to use artificial intelligence to identify new drug targets and develop potential treatments ...

India’s Drug Market Grows 17.1% in September 2026 as Global Pharma Companies Accelerate Innovation, Capacity Expansion and ...

TDB-DST signs agreement with Peptris to accelerate AI-driven drug discovery and development: Our Bureau, Mumbai Tuesday, October 13, 2026, 13:30 Hrs [IST] In a significant step to ...

Deals for AI discovery platforms and differentiated experimental candidates for obesity and solid tumors dominated the week.